A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
Comedian Nikki Glaser, host of the 2025 Golden Globe Awards ceremony, dove right in at the start of her opening monologue: ...
While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...
The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...
Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, ...
Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?
Users of GLP-1 drugs in the US cut their grocery spending by an average of 5.5% in the six months after taking the medication, a study shows.